BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32441989)

  • 1. Devising a Tier-based Skin Sensitisation Screening Strategy for Personal Care and Cosmetic Products.
    Fung ES; Towle KM; Monnot AD
    Altern Lab Anim; 2020 Mar; 48(2):70-77. PubMed ID: 32441989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tier-based skin irritation testing of hair cleansing conditioners and their constituents.
    Fung ES; Novick RM; Drechsel DA; Towle KM; Paustenbach DJ; Monnot AD
    Cutan Ocul Toxicol; 2019 Mar; 38(1):44-47. PubMed ID: 30124079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
    Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
    Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin sensitisation testing in practice: Applying a stacking meta model to cosmetic ingredients.
    Tourneix F; Alépée N; Detroyer A; Eilstein J; Ez-Zoubir M; Teissier SM; Noçairi H; Piroird C; Basketter D; Del Bufalo A
    Toxicol In Vitro; 2020 Aug; 66():104831. PubMed ID: 32198056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An
    Monnot AD; Towle KM; Ahmed SS; Dickinson AM; Fung ES
    Toxicol Mech Methods; 2021 Mar; 31(3):205-211. PubMed ID: 33371753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
    Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
    Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Safety Assessment of Cosmetic Perfumes by Using
    Dvořáková M; Svobodová L; Rucki M; Ševčík V; Hošíková B; Chrz J; Bendová H; Kejlová K; Očadlíková D; Malý M; Kolářová H; Mannerström M; Kanďárová H; Jírová D
    Altern Lab Anim; 2023 Jul; 51(4):224-248. PubMed ID: 37377062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.
    Goebel C; Aeby P; Ade N; Alépée N; Aptula A; Araki D; Dufour E; Gilmour N; Hibatallah J; Keller D; Kern P; Kirst A; Marrec-Fairley M; Maxwell G; Rowland J; Safford B; Schellauf F; Schepky A; Seaman C; Teichert T; Tessier N; Teissier S; Weltzien HU; Winkler P; Scheel J
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):40-52. PubMed ID: 22374415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information.
    Gilmour N; Alépée N; Hoffmann S; Kern PS; Van Vliet E; Bury D; Miyazawa M; Nishida H; Cosmetics Europe
    ALTEX; 2023; 40(3):439-451. PubMed ID: 36919358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to resolve inconclusive predictions from defined approaches for skin sensitisation in OECD Guideline No. 497.
    Macmillan DS; Chilton ML; Gao Y; Kern PS; Schneider SN
    Regul Toxicol Pharmacol; 2022 Nov; 135():105248. PubMed ID: 36007801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
    Indans I
    Toxicol Lett; 2002 Feb; 127(1-3):177-82. PubMed ID: 12052656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of peptide reactivity assays for skin sensitisation hazard identification and risk assessment.
    Gerberick GF
    Altern Lab Anim; 2016 Oct; 44(5):437-442. PubMed ID: 27805826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment.
    Maxwell G; Aeby P; Ashikaga T; Bessou-Touya S; Diembeck W; Gerberick F; Kern P; Marrec-Fairley M; Ovigne JM; Sakaguchi H; Schroeder K; Tailhardat M; Teissier S; Winkler P
    ALTEX; 2011; 28(1):50-5. PubMed ID: 21311850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 activation as a key event triggered by skin sensitisers: The development of the stable KeratinoSens reporter gene assay.
    Natsch A; Emter R
    Altern Lab Anim; 2016 Oct; 44(5):443-451. PubMed ID: 27805827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety assessment of a novel active ingredient, acetyl aspartic acid, according to the EU Cosmetics Regulation and the Scientific Committee on Consumer Safety guidelines.
    Daly P; Moran G
    Int J Cosmet Sci; 2015 Oct; 37 Suppl 1():21-7. PubMed ID: 26114401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.
    Kreiling R; Gehrke H; Broschard TH; Dreeßen B; Eigler D; Hart D; Höpflinger V; Kleber M; Kupny J; Li Q; Ungeheuer P; Sauer UG
    Regul Toxicol Pharmacol; 2017 Nov; 90():262-276. PubMed ID: 28958912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of the Cosmetics Europe skin sensitisation database with new substances and PPRA data.
    Hoffmann S; Alépée N; Gilmour N; Kern PS; van Vliet E; Boislève F; Bury D; Cloudet E; Klaric M; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Tam Brami MT; Varçin M; Api AM; Europe C
    Regul Toxicol Pharmacol; 2022 Jun; 131():105169. PubMed ID: 35447229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting skin sensitisation using a decision tree integrated testing strategy with an in silico model and in chemico/in vitro assays.
    Macmillan DS; Canipa SJ; Chilton ML; Williams RV; Barber CG
    Regul Toxicol Pharmacol; 2016 Apr; 76():30-8. PubMed ID: 26796566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic evaluation of non-animal test methods for skin sensitisation safety assessment.
    Reisinger K; Hoffmann S; Alépée N; Ashikaga T; Barroso J; Elcombe C; Gellatly N; Galbiati V; Gibbs S; Groux H; Hibatallah J; Keller D; Kern P; Klaric M; Kolle S; Kuehnl J; Lambrechts N; Lindstedt M; Millet M; Martinozzi-Teissier S; Natsch A; Petersohn D; Pike I; Sakaguchi H; Schepky A; Tailhardat M; Templier M; van Vliet E; Maxwell G
    Toxicol In Vitro; 2015 Feb; 29(1):259-70. PubMed ID: 25448812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of the human Cell Line Activation Test (h-CLAT) to Animal-Product-Free Conditions.
    Edwards A; Roscoe L; Longmore C; Bailey F; Sim B; Treasure C
    ALTEX; 2018; 35(4):477-488. PubMed ID: 29901211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.